Authors:
Sakatani, T
Shimazaki, C
Hirai, H
Okano, A
Hatsuse, M
Okamoto, A
Takahashi, R
Ashihara, E
Inaba, T
Yokota, H
Nakahara, K
Hirai, H
Nakagawa, M
Citation: T. Sakatani et al., Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: Importance of monitoring for WT1-mRNA quantitatively, LEUK LYMPH, 42(1-2), 2001, pp. 225-229
Authors:
Ashihara, E
Shimazaki, C
Hirai, H
Inaba, T
Hasegawa, G
Mori, S
Nakagawa, M
Citation: E. Ashihara et al., Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube, INT J HEMAT, 74(3), 2001, pp. 327-332
Authors:
Shimazaki, C
Inaba, T
Okano, A
Hatsuse, M
Takahashi, R
Hirai, H
Sudo, Y
Ashihara, E
Adachi, Y
Murakami, S
Saigo, K
Tsuda, H
Fujita, N
Nakagawa, M
Citation: C. Shimazaki et al., Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): Comparison of CD5(+) with CD5(-) B-LAHS, INTERN MED, 40(9), 2001, pp. 878-882
Authors:
Hirai, H
Shimazaki, C
Hatsuse, M
Okano, A
Ashihara, E
Inaba, T
Murakami, S
Saigo, K
Nakagawa, M
Citation: H. Hirai et al., Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndrome, LEUKEMIA, 15(2), 2001, pp. 311-312
Authors:
Ohnishi, K
Ino, T
Kishimoto, Y
Usui, N
Shimazaki, C
Ohtake, S
Taguchi, H
Kusumoto, S
Kuriyama, K
Hotta, T
Ohno, R
Citation: K. Ohnishi et al., Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis, CANC CHEMOT, 48, 2001, pp. S59-S64
Authors:
Okano, A
Shimazaki, C
Ochiai, N
Hatsuse, M
Takahashi, R
Ashihara, E
Inaba, T
Fujita, N
Noda, Y
Nakagawa, M
Citation: A. Okano et al., Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation, BONE MAR TR, 28(7), 2001, pp. 709-711
Authors:
Inaba, T
Shimazaki, C
Sumikuma, T
Ochiai, N
Okano, A
Hatsuse, M
Ashihara, E
Kobayashi, Y
Rin, K
Murakami, S
Haruyama, H
Fujita, N
Nakagawa, M
Citation: T. Inaba et al., Clinicopathological features of myeloid/natural killer (NK) cell precursoracute leukemia, LEUK RES, 25(2), 2001, pp. 109-113
Authors:
Takahashi, R
Shimazaki, C
Inaba, T
Okano, A
Hatsuse, M
Okamoto, A
Hirai, H
Ashihara, E
Nakagawa, M
Citation: R. Takahashi et al., A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells, LEUK RES, 25(1), 2001, pp. 77-83
Authors:
Yamamoto, Y
Kiyoi, H
Nakano, Y
Suzuki, R
Kodera, Y
Miyawaki, S
Asou, N
Kuriyama, K
Yagasaki, F
Shimazaki, C
Akiyama, H
Saito, K
Nishimura, M
Motoji, T
Shinagawa, K
Takeshita, A
Saito, H
Ueda, R
Ohno, R
Naoe, T
Citation: Y. Yamamoto et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, BLOOD, 97(8), 2001, pp. 2434-2439
Authors:
Naoe, T
Takeyama, K
Yokozawa, T
Kiyoi, H
Seto, M
Uike, N
Ino, T
Utsunomiya, A
Maruta, A
Jin-Nai, I
Kamada, N
Kubota, Y
Nakamura, H
Shimazaki, C
Horiike, S
Kodera, Y
Saito, H
Ueda, R
Wiemels, J
Ohno, R
Citation: T. Naoe et al., Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia, CLIN CANC R, 6(10), 2000, pp. 4091-4095
Authors:
Okamoto, T
Kanamaru, A
Shimazaki, C
Motoji, T
Takemoto, Y
Takahashi, M
Fukushima, T
Takeshita, A
Kusumoto, S
Kishimoto, Y
Yorimitsu, S
Tsukuda, K
Uike, N
Arima, N
Ohno, R
Citation: T. Okamoto et al., Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): Results of an interim analysis, INT J HEMAT, 72(2), 2000, pp. 200-205
Authors:
Nakano, Y
Naoe, T
Kiyoi, H
Kitamura, K
Minami, S
Miyawaki, S
Asou, N
Kuriyama, K
Kusumoto, S
Shimazaki, C
Akiyama, H
Saito, K
Nishimura, M
Motoji, T
Shinagawa, K
Saito, H
Ohno, R
Citation: Y. Nakano et al., Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia, EUR J HAEMA, 65(1), 2000, pp. 23-31
Authors:
Ashihara, E
Shimazaki, C
Okano, A
Hatsuse, M
Inabe, T
Nakagawa, M
Citation: E. Ashihara et al., Feasibility and efficacy of high-dose etoposide followed by low-dose granulocyte colony-stimulating factor as a mobilization regimen in patients withnon-Hodgkin's lymphoma, HAEMATOLOG, 85(10), 2000, pp. 1112-1114
Authors:
Kikuta, T
Shimazaki, C
Ashihara, E
Sudo, Y
Hirai, H
Sumikuma, T
Yamagata, N
Inaba, T
Fujita, N
Kina, T
Nakagawa, M
Citation: T. Kikuta et al., Mobilization of hematopoietic primitive and committed progenitor cells into blood in mice by anti-vascular adhesion molecule-1 antibody alone or in combination with granulocyte colony-stimulating factor, EXP HEMATOL, 28(3), 2000, pp. 311-317
Authors:
Inaba, T
Shimazaki, C
Sumikuma, T
Nakagawa, M
Citation: T. Inaba et al., Myeloid/natural killer (NK) cell precursor acute leukemia seems not rare among acute myeloid leukemia of M0 subtype (AML-M0), LEUK RES, 24(6), 2000, pp. 551-551
Authors:
Wada, M
Mizoguchi, H
Kuriya, S
Taguchi, H
Kawamura, T
Maekawa, I
Shimazaki, C
Sato, Y
Niho, Y
Miyazaki, T
Shibata, A
Kitani, T
Hamajima, N
Ohno, R
Citation: M. Wada et al., Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon alpha (ROAD-IN) and a randomized comparison of interferon alpha maintenance in multiple myeloma: a co-operative study in Japan, BR J HAEM, 109(4), 2000, pp. 805-814
Authors:
Inaba, T
Shimazaki, C
Sumikuma, T
Okano, A
Hatsuse, M
Okamoto, A
Takahashi, R
Ashihara, E
Hibi, S
Sudo, Y
Yamagata, N
Murakami, S
Rin, K
Fujita, N
Yoshimura, M
Nakagawa, M
Citation: T. Inaba et al., Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphoma, BR J HAEM, 109(3), 2000, pp. 592-599
Authors:
Miyawaki, S
Tanimoto, M
Kobayashi, T
Minami, S
Tamura, J
Omoto, E
Kuriyama, K
Hatake, K
Saito, K
Kanamaru, A
Oh, H
Ohtake, S
Asou, N
Sakamaki, H
Yamada, O
Jinnai, I
Tsubaki, K
Takeyama, K
Hiraoka, A
Matsuda, S
Takahashi, M
Shimazaki, C
Adachi, K
Kageyama, S
Sakura, T
Ohno, R
Citation: S. Miyawaki et al., No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study, INT J HEMAT, 70(2), 1999, pp. 97-104
Authors:
Ashihara, E
Shimazaki, C
Okamoto, A
Shimura, K
Takahashi, R
Sumikuma, T
Hirai, H
Inaba, T
Fujita, N
Nakagawa, M
Citation: E. Ashihara et al., Successful peripheral blood stem cell transplantation for myelodysplastic syndrome, BONE MAR TR, 24(12), 1999, pp. 1343-1345
Authors:
Shimazaki, C
Inaba, T
Shimura, K
Okamoto, A
Takahashi, R
Hirai, H
Sudo, Y
Ashihara, E
Adachi, Y
Murakami, S
Saigo, K
Fujita, N
Nakagawa, M
Citation: C. Shimazaki et al., B-cell lymphoma associated with haemophagocytic syndrome: a clinical, immunological and cytogenetic study, BR J HAEM, 104(4), 1999, pp. 672-679
Authors:
Kiyoi, H
Naoe, T
Nakano, Y
Yokota, S
Minami, S
Miyawaki, S
Asou, N
Kuriyama, K
Jinnai, I
Shimazaki, C
Akiyama, H
Saito, K
Oh, H
Motoji, T
Omoto, E
Saito, H
Ohno, R
Ueda, R
Citation: H. Kiyoi et al., Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia, BLOOD, 93(9), 1999, pp. 3074-3080
Authors:
Inaba, T
Shimazaki, C
Sumikuma, T
Shimura, K
Takahashi, R
Hirai, H
Ashihara, E
Sudo, Y
Murakami, S
Haruyama, H
Fujita, N
Yoshimura, M
Nakagawa, M
Citation: T. Inaba et al., Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome, INT J HEMAT, 68(4), 1998, pp. 403-410
Authors:
Satoh, E
Hirai, H
Inaba, T
Shimazaki, C
Nakagawa, M
Imanishi, J
Mazda, O
Citation: E. Satoh et al., Successful transfer of ADA gene in vitro into human peripheral blood CD34(+) cells by transfecting EBV-based episomal vectors, FEBS LETTER, 441(1), 1998, pp. 39-42